$34.21
-1.76-4.89%
At close: -
$34.05
-0.16-0.47%
After Hours: Jan 31, 7:07 PM EDT
Comments
Loading...
BridgeBio Pharma (NASDAQ:BBIO) Stock, Earnings Estimates, EPS, And Revenue
BridgeBio Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 20
EPS Estimate
$-1.090
Quarterly Revenue Estimate
$39.31M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$217.76M
Analyze the earnings history of BridgeBio Pharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
BridgeBio Pharma (BBIO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.86 | $-0.98 | 12.2 % |
| Q2 | 2024-08-01 | $-1.06 | $-1.04 | -1.92 % |
| Q1 | 2024-05-02 | $-0.20 | $-0.89 | 77.5 % |
| Q4 | 2024-02-22 | $-0.96 | $-0.91 | -5.49 % |
BridgeBio Pharma (BBIO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $2.73M | $3.76M | -27.3 % |
| Q2 | 2024-08-01 | $2.17M | $3.57M | -39.3 % |
| Q1 | 2024-05-02 | $211.12M | $14.03M | 1404.8 % |
| Q4 | 2024-02-22 | $1.75M | $6.23M | -72.0 % |
FAQ
When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?
BridgeBio Pharma (BBIO) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for BridgeBio Pharma (NASDAQ:BBIO)?
The Actual EPS was $-0.86, which beat the estimate of $-0.98.
What were BridgeBio Pharma’s (NASDAQ:BBIO) revenues?
The Actual Revenue was $2.7M, which missed the estimate of $3.8M.
Browse earnings estimates, EPS, and revenue on all stocks.